Navigation Links
Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego
Date:2/23/2011

SAN DIEGO, Feb. 23, 2011 /PRNewswire/ -- Thomas, McNerney & Partners, LLC, a health care venture capital firm that invests in life science and medical technology companies, will be relocating its West Coast office from San Francisco to San Diego.  Thomas, McNerney partner Pratik Shah, Ph.D. announced the move at BIOCOM's first global partnering conference being held in San Diego.

"Southern California is home to many top-tier scientific and medical centers; it's long been a fertile breeding ground for successful medical technology companies, and it's populated by some of the smartest, most capable people in the country," Dr. Shah said.  "It has all the ingredients that make it an ideal home for Thomas, McNerney's West Coast office." Thomas, McNerney & Partners has ten investments on the West Coast, six of which are in Southern California.

In addition, well known San Diego biopharmaceutical executive Larry Fritz, Ph.D. has joined Thomas, McNerney as an Entrepreneur in Residence and will be based out of the firm's new West Coast office.  Dr. Fritz has founded or co-founded a string of successful biotechnology companies including Athena Neurosciences, Idun, Conforma, Cabrellis and Covella.  He will assist Thomas, McNerney in selecting investments and building companies.  

"Larry has had a long and distinguished career in founding and managing biotechnology companies," said Dr. Shah.  "Importantly, he has been especially successful in creating value for investors and engineering profitable exits in multiple private companies.  Strategically, operationally and scientifically, he is a good fit for the way we do business at Thomas, McNerney, and he will be a great addition to our team."

About Thomas, McNerney & Partners

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management, focused on investing in life science and medic
'/>"/>

SOURCE Thomas, McNerney & Partners, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Johnson & Johnson to Participate in 2011 Citi Global Health Care Conference
2. Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional
3. Smith & Nephews Exclusive OXINIUM™ Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japanese Market
4. Smith & Nephew Enables Minimally Invasive and Anterior Approach Hip Replacement Surgeries With Launch of Modular, Mini Hip Stem
5. Reportlinker Adds U.S. Pain Management Products & Services: a Market Analysis - 7th Edition
6. AT&T Connected Vitality GlowCaps Wins 2011 Global Mobile Award
7. Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds
8. NeoStem to Present at 13th Annual BIO CEO & Investor Conference
9. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
10. Sutter Health Among the Nations Top Employers According to Readers of CAREERS & the disABLED Magazine
11. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Developed by AstraZeneca plc, quetiapine ... important drug for the treatment of schizophrenia. Approved ... was listed in the Catalogue of Drugs for ...
(Date:8/28/2015)... 28, 2015 The scientific team of ... one of the leading academics in the field of aging ... holder in life extension for model animals - 10 fold ... aging and age-related diseases, primarily, around the stability and stress ... been published as "Stability analysis of a model gene network ...
(Date:8/28/2015)... and ATLANTA , August 28, 2015 ... Food and Drug Administration (FDA) cleared the MagVita TMS Therapy ... patients who have failed to receive satisfactory improvement from prior ... technique for stimulating neural tissue in the part of the ... procedure has been proven safe and effective and MagVenture is ...
Breaking Medicine Technology:China Quetiapine Market Investigation Report 2010-2019 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3
... Colo., Oct. 17 Pharmion Corporation,(Nasdaq: PHRM ... pivotal,Phase 3 clinical trial evaluating amrubicin, the Company,s ... cell lung,cancer (SCLC). The randomized, controlled, multi-center study ... for second-line,treatment of SCLC in the US and ...
... and Bare ... Metal Stents, ... Adjudication Study) trial of OrbusNeich,s,Genous Bio-engineered R stent has reached 110 ... de Winter, M.D., Ph.D.,principal investigator and director of the catheterization laboratory ...
Cached Medicine Technology:Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer 2Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer 3Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer 4Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer 5Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) 2
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL —Pocket ... zero fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. ... SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were ...
(Date:8/28/2015)... ... 2015 , ... The Nashville Business Journal recently announced its ... Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one of ... Awards will recognize Nashville military veterans who, through their professional and personal efforts, ...
(Date:8/28/2015)... ... August 28, 2015 , ... Northridge dentists Dr. ... whitening. For just $199, patients can currently receive a one hour treatment of this ... procedures, but it includes a number of unique features that can turn teeth up ...
(Date:8/28/2015)... ... August 28, 2015 , ... The newest therapy to receive orphan drug ... use any time soon, according to educational website Surviving Mesothelioma. Click here to ... drug designation for mesothelioma last week from the FDA, will now head into Phase ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... now consolidated as MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in ... number of custodial files the PSC may receive for corporate employees involved in ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4
... finds , , WEDNESDAY, Nov. 19 (HealthDay News) -- ... is roughly the same no matter what the patient,s ... disparities in our health care system have been well ... artery disease, congestive heart failure, renal failure, acute appendicitis ...
... Rendell today revised his July 8 executive order extending the ... Under the revised order, the council will remain in operation ... the council, whichever occurs first. , ... PHC4 was allowed to "sunset" by the General Assembly. It ...
... Educate Health Care Stakeholders , ... The Virginia Business Coalition on Health (VBCH) announced its ... efforts initiated by the Center for Medicare and Medicaid ... Events" - serious and costly preventable hospital errors. Effective ...
... Leaves Skin Consistently Smooth and Visibly Tight , ... Body-sculpting technology with consistently smooth, visibly tight results ... now available to those who want effective body reshaping ... leader in aesthetic body shaping technology, SmoothLipo is a ...
... Nov. 19 (HealthDay News) -- The dietary supplement beta-alanine ... -- improves muscle endurance in the elderly, according to ... the prevention of falls, and the maintenance of health ... study author Jeffrey Stout of the University of Oklahoma. ...
... Researchers at Southern Methodist University in Dallas are pioneering ... scan data from Persian Gulf War veterans, aiming to ... Gulf War Syndrome. , Richard Gunst, Wayne Woodward and ... collaborating with imaging specialists at UT Southwestern Medical Center ...
Cached Medicine News:Health News:Patient's Race Doesn't Affect Emergency Room Care 2Health News:Governor Rendell Revises Executive Order; Extends Operation of PA Health Care Cost Containment Council 2Health News:Governor Rendell Revises Executive Order; Extends Operation of PA Health Care Cost Containment Council 3Health News:Virginia Business Coalition on Health Issues Statement of Support for Hospital Improvement 2Health News:Virginia Business Coalition on Health Issues Statement of Support for Hospital Improvement 3Health News:Eleme Medical Launches SmoothLipo(TM) Body Shaping Treatment 2Health News:Deep brain mapping to isolate evidence of Gulf War syndrome 2
... ICP Monitoring System provides ... intracranial pressure at the ... levels. The information is ... through a hydrostatic column ...
The Optical Tracking System provides a complete solution for image-guided surgery. Precision tracking technology converges with powerful visualization software for optimal surgical planning and navig...
Penfield Dissector #2...
ScalpFix scalp clip system includes an reusable handle, scalp clips, sterile packed cartridges and removal forceps. It is easy to use, time saving and fast application....
Medicine Products: